Shire’s stalker raises its offer

US pharmaceuticals group AbbVie has made a fourth attempt to bag London-listed Shire Pharmaceuticals.

US pharmaceuticals group AbbVie has made a fourth attempt to bag London-listed Shire Pharmaceuticals. Its latest unsolicited bid is worth £30bn, or just over £51 a share an 11% improvement on the previous bid.

AbbVie urged Shire's shareholders to persuade the board to enter talks. AbbVie is best known for Humira, a rheumatoid arthritis drug. Shire specialises in drugs for attention deficit hyperactivity disorder.

What the commentators said

Back then, it was easy to point out that Pfizer was keen to take over Astra largely for tax purposes: it would keep its bills down by moving its domicile to the UK.

But this situation is different. While so-called tax inversion plays a part in AbbVie's motives, "Shire's role as a UK pharmaceutical powerhouse is undermined" by its own tax exile in Ireland, said Brummer; it has been based there for eight years. If AbbVie takes it over, Shire will actually come home.

In any case, Shire has never been a "research and development champion" in the Astra or GlaxoSmithKline mould.It has expanded largely by acquisition.

Plenty of shareholders will be happy with the offer, said Nils Pratley in The Guardian the shares traded at £35 before the bid surfaced. But AbbVie can pay more. Bank of America reckons it could stretch to £59 and still break even.

Shire's own growth target will also bolster its defences, said Navid Malik of Cenkos. It plans to double revenue by 2020, achievable given its "track record of building value". "Its value as a stand-alone company is very compelling."

Recommended

Stockmarkets shrug off turbulence
Stockmarkets

Stockmarkets shrug off turbulence

Stockmarkets have hit their first bout of turbulence of the year, but most are clinging onto January’s gains.
4 Feb 2021
The MoneyWeek Podcast: how to not lose money to inflation and financial repression
Investment strategy

The MoneyWeek Podcast: how to not lose money to inflation and financial repression

Merryn talks to Peter Spiller of the Capital Gearing Trust about how he navigated the last extraordinary year; what he's buying now; and how he plans …
16 Apr 2021
UK mid-cap stocks look forward to life after lockdown
UK stockmarkets

UK mid-cap stocks look forward to life after lockdown

The FTSE 250 hit an all-time high at the end of last week, as investors look to a post-lockdown recovery.
16 Apr 2021
Why you should expect another stockmarket crash
Stockmarkets

Why you should expect another stockmarket crash

Many fear inflation, but a deflationary debt collapse is a more likely scenario in the near term, says Tim Lee
16 Apr 2021

Most Popular

The bitcoin bubble will burst: here’s how to play it
Bitcoin

The bitcoin bubble will burst: here’s how to play it

The cryptocurrency’s price has soared far beyond its fundamentals, says Matthew Partridge. Here, he looks at how to short bitcoin.
12 Apr 2021
What does the Coinbase listing mean for bitcoin and other cryptocurrencies?
Bitcoin

What does the Coinbase listing mean for bitcoin and other cryptocurrencies?

As the bitcoin price hit new highs, the world's biggest cryptocurrency exchange, Coinbase, listed on the stockmarket. John Stepek looks at what that m…
15 Apr 2021
Properties for sale for around £400,000
Houses for sale

Properties for sale for around £400,000

From a converted church in Banffshire with views towards the Cairngorms National Park, to a period property in the Georgian market town of Beverley, e…
2 Apr 2021